Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that it has submitted a Biologics ...
Dr Dana Chase recalls early-career experiences and describes how revolutionary advances in surgery and personalized medicine ...
Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...
Phanes Therapeutics reports positive phase 2 results of spevatamig in combo with chemotherapy in frontline treatment of metastatic PDAC: San Diego Monday, January 12, 2026, 18:00 ...
Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO G I), comparing cadonilimab ...
AbbVie said on Monday it would partner with Chinese drug developer RemeGen for an experimental treatment targeting solid ...
Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...
Ibuprofen’s anti-inflammatory action may influence cancer risk, but evidence remains complex and routine use for prevention is not advised. Ibuprofen is one of the most widely used pain relievers, ...
A team of researchers has demonstrated how advanced robotics combined with click chemistry can dramatically accelerate the ...
A mother who experienced a sudden sharp pain while doing yoga said her first thought when she was diagnosed was whether her ...
A mother who experienced a sudden sharp pain in her breast while practising yoga has been diagnosed with lobular breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback